Background Undifferentiated-type early gastric adenocarcinomas are generally classified into two groups: pure undifferentiated-type adenocarcinomas, which naturally develop as undifferentiated-type without a glandular component; and mixed differentiated/undifferentiated-type adenocarcinomas, which are associated with some vestigial glandular component and presumably develop from differentiated-type adenocarcinoma. The differences in phenotypic expression between these two groups were examined using mucin core protein and CDX2. Methods A total of 210 lesions of undifferentiated-type early gastric adenocarcinoma less than 25 mm in diameter were classified into four categories (gastric type, gastrointestinal type, intestinal type, and null type) based on their MUC5AC, MUC6, MUC2, and CDX2 immunoprofiles. Results Gastric type was significantly (p \ 0.01) decreased and gastrointestinal type was significantly (p \ 0.01) increased both in pure undifferentiated-type adenocarcinomas and in mixed differentiated/undifferentiated-type adenocarcinomas when CDX2 was applied to mucin core protein. In the pure undifferentiated-type adenocarcinomas, gastric type decreased and gastrointestinal type increased as tumor size increased (p \ 0.05). In contrast, in the mixed differentiated/undifferentiated-type adenocarcinomas, gastrointestinal type was most common even in small-sized (B10 mm) carcinomas and was generally stable regardless of tumor size. In submucosal carcinomas, gastrointestinal type decreased and gastric type and intestinal type increased during carcinoma invasion from the intramucosal to submucosal parts (p \ 0.05). The positivity rates for all phenotypic markers, especially gastric markers, tended to decrease during submucosal invasion. Conclusions CDX2 is a sensitive marker for assessing intestinal phenotypic expression, and it is likely that there are two different pathways of tumor progression in undifferentiated-type adenocarcinoma of the stomach, according to phenotypic expression.
Introduction
Histologically, human gastric adenocarcinomas have been classified into two major groups by Lauren [1] -the intestinal type and the diffuse type (depending on the degree of glandular formation of the cancer cells)-a classification which roughly corresponds to the differentiated type and undifferentiated type, respectively [2] . It has been considered that the differentiated types arise from intestinalized mucosa and take an intestinal phenotype, while the undifferentiated types develop from atrophic gastric mucosa without intestinal metaplasia and take a gastric phenotype [3, 4] . This hypothesis is based on morphological similarities between cancers and intestinal metaplasia, as well as being based on the results of comparisons between carcinomas and the surrounding mucosa. However, recent advances in mucin immunohistochemistry, including mucin core protein (MUC), have revealed that differentiated-type adenocarcinomas are composed of both intestinal and gastric phenotypes [5] [6] [7] [8] .
Previous investigations of the phenotypic expression of undifferentiated-type adenocarcinomas are limited, and it has been reported that there are some undifferentiated-type adenocarcinomas of intestinal phenotype [9, 10] , and that the intestinal phenotype in gastric signet-ring cell carcinomas appears to occur during tumor progression [11] [12] [13] or during tumor spread in the mucosa [14] . However, how frequent and when phenotypic alteration occurs during the development of undifferentiated-type adenocarcinomas remain controversial.
There are several commercial markers that are useful for distinguishing gastric carcinoma phenotypes. The caudalrelated homeobox gene CDX2 is important for the maintenance of intestinal epithelial cells [15] , and there have been several reports of CDX2 expression in human gastric carcinomas and intestinal metaplasia [16] [17] [18] [19] [20] . It has previously been shown that CDX2 is closely associated with intestinal phenotypic expression in gastric carcinomas [17] [18] [19] 21] . However, few studies have evaluated phenotypic expression in undifferentiated-type adenocarcinoma and/or signet-ring cell carcinoma using CDX2 as a phenotypic marker [16, 17, 22, 23] .
It has been reported that, as gastric adenocarcinoma invades deeply or increases in size, the incidence of differentiated-type decreases and that of undifferentiated-type increases [24] [25] [26] , which raises the possibility of histological transformation from differentiated-type to undifferentiated-type during tumor progression. Furthermore, differentiated-type adenocarcinomas of the gastric phenotype are considered to have higher rates of histological transformation into undifferentiated-type adenocarcinomas, as well as higher biological malignancy, such as high invasiveness and high metastatic potential, compared with those of the intestinal phenotype [27] . In contrast, even minute gastric adenocarcinomas, up to 5 mm in size and considered to be incipient in carcinogenesis, contain a certain amount of pure undifferentiated-type adenocarcinoma. These findings allow us to postulate different development pathways for undifferentiated-type adenocarcinoma: one that naturally develops as undifferentiatedtype without a glandular component (pure undifferentiatedtype: PURE-type); and one that develops with some rudimentary glandular component (mixed undifferentiatedtype and differentiated-type: MIXED-type), presumably from differentiated-type adenocarcinoma.
The aim of this study was to clarify the differences in phenotypic expression between these two groups of undifferentiated-type adenocarcinomas: PURE-type carcinoma and MIXED-type carcinoma. For this purpose, (1) two different criteria of phenotypic classification were compared (immunoprofile based on MUC only and that based on MUC and CDX2 combined), and (2) differences in phenotypic expression between PURE-type carcinoma and MIXED-type carcinoma were examined according to the background mucosa, depth of tumor invasion, and tumor size.
Materials and methods

Patients, lesions, and tissue sampling
From our pathological files of gastric carcinomas from July 1979 through March 2006, 210 lesions of undifferentiatedtype early gastric adenocarcinomas measuring less than 25 mm in diameter were selected for this study. All tumors had been surgically resected, from 203 Japanese patients who had had no systemic adjuvant therapy, at Niigata University General Hospital and its affiliated institutions. Each surgically resected specimen was fixed in 10 % buffered neutral formalin solution and serially cut into 5-mmthick sections throughout each lesion and embedded in paraffin. All sections were stained with hematoxylin-eosin (HE) for histological examination. Paraffin blocks corresponding to the selected HE sections were cut into 3-lmthick consecutive sections for immunohistochemical staining.
The histological classification was based on the Japanese classification of gastric carcinoma [28] . Undifferentiated-type adenocarcinomas were defined as those with indistinct or no glandular structure, including solid-type, poorly differentiated adenocarcinoma (por1); non-solidtype, poorly differentiated adenocarcinoma (por2); and signet-ring cell carcinoma (sig). The undifferentiated-type adenocarcinomas were further subclassified into two groups: (1) PURE-type, without any glandular formation; and (2) MIXED-type, with a mixture of non-glandular (POR) and some vestigial glandular (TUB) components.
Immunohistochemical staining
For antigen retrieval, the deparaffinized sections were microwave-treated at approximately 98°C for 20 min (sections for MUC5AC/HGM, MUC6, MUC2, and CDX2) in 10 mmol/L citrate buffer (pH 6.0, except for Definition of phenotypes of carcinomas MUC5AC, HGM, MUC6, and M-GGMC-1 were defined as gastric phenotype markers, whereas MUC2 and CDX2 were selected as intestinal phenotype markers. It has been reported that MUC5AC and MUC6 recognize core proteins, whereas HGM and M-GGMC-1 recognize carbohydrate side-chains [8, [29] [30] [31] . Cytoplasmic reactivity was judged as positive for MUC5AC/HGM, MUC6/M-GGMC-1, and MUC2, and nuclear reactivity was judged as positive for CDX2. Samples were classified as positive if 5 % or more of the tumor cells were stained; otherwise they were considered negative [8, 16, 22] . Using these markers, the phenotypes were classified into four categories: (1) gastric type (G type), demonstrating positive expression for gastric markers but negative expression for intestinal markers (Fig. 1) ; (2) intestinal type (I type), demonstrating positive expression for intestinal markers but negative expression for gastric markers (Fig. 2) ; (3) gastrointestinal type (GI type), demonstrating positive expression both for gastric and intestinal markers (Fig. 3) ; and (4) null type (N type), with negative expression for all markers. Furthermore, to compare our findings with previous reports that did not use CDX2 as a phenotypic marker, the carcinoma phenotypes were separately evaluated in two steps: phenotype judged by MUC only, and that judged by MUC and CDX2 combined. In the MIXED-type group, phenotypes in the POR component and in the TUB component were analyzed separately. Similarly, in submucosal invasive tumors, phenotypes of the intramucosal part and of the submucosal part were analyzed separately (Fig. 4) .
Evaluation of surrounding mucosa
The surrounding non-neoplastic mucosa within 5 mm of the margins of the carcinoma cells was evaluated with respect to degree of chronic inflammation, polymorphonuclear neutrophil activity, degree of glandular atrophy, and degree of intestinal metaplasia, based on the updated Sydney system [32] .
Statistical analysis
Statistical analysis was performed using the v 2 test, Fisher's exact test, and the unpaired t-test. Bonferroni's method was used for multiple comparisons. All statistical analyses were performed using the PASW statistics 17 software package (SPSS Japan, Tokyo, Japan). A two-tailed p value of less than 0.05 was considered significant.
Results
Clinicopathological findings
The clinicopathological findings of the 106 PURE-type carcinomas and the 104 MIXED-type carcinomas are Table 1 . Submucosal invasive carcinomas were more frequent in the MIXED-type than in the PUREtype (p \ 0.001). The proportion of male subjects tended to be higher in the MIXED-type than in the PURE-type, but there were no significant differences in age, sex, tumor location, macroscopic type, or tumor size between these two types.
Histopathological findings of surrounding mucosa
The histology of the non-neoplastic surrounding mucosa is summarized in vs. 83.7 % in the TUB components of MIXED-type carcinomas; p \ 0.01). Thus, G type was most common based on MUC only, though GI type was most common based on MUC and CDX2 in each group (p \ 0.01). However, in both classifications, there was no significant difference in phenotype distribution among the three groups ( Table 3) .
As for the expression of each phenotypic marker, the positivity rate for MUC5AC was significantly higher in PURE-type carcinomas than in the POR component of MIXED-type carcinomas (p \ 0.01). The positivity rate for MUC2 tended to be lower in the POR component than in the TUB component of MIXED-type carcinomas. CDX2 expression was detected not only in MUC2-positive cells but also in MUC2-negative cells (Figs. 2, 3) , and there were no significant differences in CDX2 expression among the three groups (Table 4) . Correlation between carcinoma size and phenotypic expression Figure 5 shows the correlation between the phenotypes and the size of carcinomas (B10 mm and [10 mm) in each of the three groups. In PURE-type carcinomas, G type decreased significantly and GI type increased significantly as carcinoma size increased (p \ 0.05; Fig. 5a, b) . In contrast, both in the POR component and in the TUB component of MIXED-type carcinomas, the prevalence of phenotypes did not change with carcinoma size (Fig. 5d , e, g, h). In PURE-type carcinomas, the positivity rates for gastric markers were generally stable, whereas the positivity rates for intestinal markers increased as carcinoma size increased; the positivity rate for CDX2 was significantly higher in the [10-mm group than in the B10-mm group (p \ 0.05), and MUC2 expression showed similar changes (Fig. 5c) . In contrast, in the POR and TUB components of MIXED-type carcinomas, the positivity rates for gastric and intestinal markers were generally stable regardless of carcinoma size; there was no significant difference in the positivity rate for each phenotypic marker by tumor size (Fig. 5f, i) .
Correlation between depth of carcinoma invasion and phenotypic expression Figure 6 shows the phenotype relationship between the intramucosal and submucosal parts in submucosal carcinoma. In PURE-type carcinomas, the GI type decreased and both the G type and I type increased during carcinoma invasion from the intramucosal to submucosal parts, and the difference was significant when the phenotype was judged by MUC and CDX2 (p \ 0.05). In the TUB component of MIXED-type carcinomas, there was also a decrease of GI type and an increase of G type and I type during submucosal carcinoma invasion, and the differences were significant regardless of the use of CDX2 (p \ 0.05; Fig. 6a , b, g, h). The positivity rate for each phenotypic marker, especially gastric markers, tended to decrease during carcinoma invasion from the intramucosal to submucosal parts in all three groups (Fig. 4) ; this tendency was significant for MUC5AC in the TUB component of MIXED-type (p \ 0.05; Fig. 6c, f, i) .
Discussion
A total of 210 lesions of undifferentiated-type early gastric adenocarcinoma less than 25 mm in diameter were immunohistochemically investigated based on mucin core proteins and CDX2 to clarify the differences between two groups of different development pathways (PURE-type carcinoma and MIXED-type carcinoma) (Fig. 7) .
As previously reported [8, [29] [30] [31] , the distribution and positivity of MUC5AC and HGM, as well as the distribution and positivity of MUC6 and M-GGMC-1, are different. In brief, of the foveolar-type mucins, MUC5AC is detected more often than HGM mucin in gastric carcinoma, because MUC5AC is basically limited to being within the cytoplasm, while HGM is confined to the luminal surface coat, as well as the cytoplasm, of gastric carcinomas. Of the pyloric gland-type mucins, MUC6 mucin is more abundant than M-GGMC-1 mucin and is restricted to the cytoplasm, whereas M-GGMC-1 mucin is sometimes found on the luminal surface coat, as well as in the cytoplasm. Therefore, in the present study, MUC5AC, HGM, MUC6, and M-GGMC-1 stains were all used to accurately determine the mucin phenotypes of gastric carcinomas. Furthermore, CDX2 was used as an intestinal phenotype marker along with MUC2. The positivity rate was higher for CDX2 than for MUC2, and CDX2 expression was detected in cancerous areas not only where MUC2 expression was apparent, but also in tissues exhibiting only gastric markers or null phenotypic lesions. Previous reports have shown that there is a positive correlation between CDX2 expression and MUC2 [21, 33] , and that CDX2 expression might precede intestinal phenotypic expression during a shift from gastric to intestinal phenotype with the progression of gastric carcinomas [17] . Thus, CDX2 appears to be a more sensitive marker than MUC2 for assessing the presence of intestinal phenotypic expression.
Based on MUC only, PURE-type carcinomas were classified as 61.3 % (65/106) G type, 34.9 % (37/106) GI type, 0.9 % (1/106) I type, and 2.8 % (3/106) N type. Previous reports have shown the rates of the G, GI, I, and N types of early undifferentiated-type adenocarcinoma, including signet-ring cell carcinoma, to be 27.8-62.4 %, 24.7-68.5 %, 0-23.1 %, and 0-10.8 %, respectively [9, 10, 13, 14, 17, 26] . In contrast to the above findings based on MUC only, PURE-type carcinomas in the present study were classified into 17.9 % (19/106) G type, 78.3 % (83/ 106) GI type, 1.9 % (2/106) I type, and 1.9 % (2/106) N type based on MUC and CDX2. The present results clearly showed that there was an unexpectedly larger population of undifferentiated-type adenocarcinomas having the intestinal phenotype or gastrointestinal phenotype as compared with previously reported phenotypes based on MUC without the use of CDX2.
On the other hand, there are some reports [17] [18] [19] 33 ] suggesting a possible tumor suppressor role for CDX2, but the significance of CDX2 expression in gastric neoplasms is still under debate. The present study targeted the expression of mucin phenotype, and the materials used were limited to early-stage gastric carcinomas sized 25 mm or less, which made it difficult to evaluate biological PURE-type carcinomas showed the gastric phenotype in 32.1 % of cases when their size was B10 mm, considered to be a very early stage of carcinogenesis. Furthermore, they also demonstrated a size-dependent increase in intestinal phenotypic markers (CDX2 and MUC2) but no correlation for gastric phenotypic markers, resulting in increased GI phenotype as tumor size increased (Fig. 5) . In contrast, in MIXED-type carcinomas, the intramucosal part showed intestinal phenotypic expression even in smallersized carcinomas (Fig. 5) . These results may allow us to consider that not a small number of PURE-type carcinomas arise with pure gastric phenotype and acquire the intestinal phenotype during mucosal development; on the other hand, a large number of MIXED-type carcinomas have the intestinal phenotype from the very early stage of carcinogenesis, and intestinal phenotypic expression tends to be reduced with morphological alteration (Fig. 7) . Bamba et al. [14] reported time-(size-) dependent expression of the intestinal phenotype in signet-ring cell carcinomas. Natsagdorj et al. [22] reported that the undifferentiatedtype gastric carcinomas derived from signet-ring cell carcinomas and the undifferentiated-type gastric carcinomas derived from differentiated-type carcinomas showed differences in intestinal phenotypic marker expressions.
In the present study, the proportion of GI type decreased and that of G and I type increased as carcinoma developed from the intramucosal to submucosal parts, and phenotypic marker expression, especially gastric markers, tended to decrease (Fig. 6 ). Each case, except for one (data not shown), individually showed phenotypic alteration with reduction of gastric and intestinal markers during submucosal invasion. These findings may suggest that the increased proportion of I type during submucosal invasion is caused not by the acquisition of intestinal marker expression, but by a reduction of gastric marker expression. In contrast, previous reports have shown that the phenotype of signet-ring cell carcinomas alters from gastric phenotype to intestinal phenotype during submucosal invasion [11] [12] [13] . It may be argued that reduced gastric phenotypic expression in the submucosal part could be caused by the selective submucosal invasion of constitutively non-gastrictype cells. However, this seems unlikely, because the pattern of phenotypic expression in tumor cells right under the muscularis mucosae was the same as that in the intramucosal part, and the submucosal part showed gradual loss of phenotypic expression. Similarly, Nakamura et al. [34] reported the loss of gastric and intestinal phenotypic expression during tumor progression in differentiated-type early gastric carcinomas. Natsagdorj et al. [22] reported that intestinal phenotypic expression was reduced with deeper extramucosal invasion, due to loss of induction by the tissue environment, in undifferentiated-type gastric carcinomas.
In conclusion, CDX2 was a more sensitive marker than MUC2 for assessing the presence of intestinal phenotypic expression from the early stage in undifferentiated-type gastric adenocarcinomas. The present data suggest that there are two different groups of undifferentiated-type gastric adenocarcinomas, PURE-type carcinomas and MIXED-type carcinomas, according to phenotype expression. It is possible that these two groups develop via different tumorigenesis pathways with differences in phenotypic alteration during tumor progression.
